After Makary's FDA exit, biopharma exhales: Signal Survey
When Endpoints Signal released the Q3 Biopharma Sentiment Index last week, it showed a level of industry optimism not seen in years. Behind the topline figure, one area of improvement really stood ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.